Plasmagen Biosciences Private Limited - Company Profile

It is a trading private limited company based in Bangalore, Karnataka, India, established in 2010.
2010 Bangalore, Karnataka, India Active
Last Updated:
Access Report
About Plasmagen Biosciences Private Limited

Plasmagen Biosciences Private Limited, a active private limited company, was established on 07 September 2010 in Bangalore, Karnataka, India. Engaging in wholesale within the trade sector, it holds CIN: U51909KA2010PTC055077. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹114.85 Cr and a paid-up capital of ₹114.34 Cr.

It upholds a compliant status. Employing 262 professional, Its leadership includes Robert Mark Weisskoff (Director), Prem Venkatachalam Pavoor (Director), Gopal Sarda (Director). Past directors included Kapil Kumar Bhawarlal Jain, Robert Mark Weisskoff, Prem Venkatachalam Pavoor. It holds ₹305.25 Cr open charges and ₹20.55 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at No. 160, Kci Chambers, 2Nd Floor, 5Th Main Road, Chamarajpet, Bangalore, Karnataka, 560018.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U51909KA2010PTC055077

  • Registration Number

    055077

  • Incorporation Date

    07 September 2010

  • Authorized Capital

    ₹114.85 Cr

  • Paid-Up Capital

    ₹114.34 Cr

  • ROC Code

    Roc Bangalore

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 114.85 Cr
  • Paid Up Capital ₹ 114.34 Cr
  • Company Age 15 Year, 6 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 305.25 Cr
  • Satisfied Charges ₹ 20.55 Cr
  • Revenue Growth **** 4.98%
  • Profit Growth **** -298.30%
  • Ebitda **** -275.76%
  • Net Worth 57.97%
  • Total Assets **** 56.77%
Company report

Plasmagen Biosciences Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Plasmagen Biosciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Plasmagen Biosciences Private Limited?
Current Directors
Name Designation Appointment Date Status
Robert Mark Weisskoff Director 28 Jul 2017 Current
Prem Venkatachalam Pavoor Director 28 Jul 2017 Current
Gopal Sarda Director 07 Jul 2017 Current
Rahul Jain Director 07 Jul 2017 Current
Vinod Nahar Managing Director 07 Sep 2010 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 01 Jul 2017 Past
Pramod Abcsdd Additional Director 28 Jul 2017 Past
Pramod Abcsdd Additional Director 28 Jul 2017 Past
Pramod Abcsdd Additional Director 08 Jul 2017 Past
Pramod Abcsdd Director 01 Jul 2017 Past
Pramod Abcsdd Director 07 Jul 2017 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Plasmagen Biosciences.

Plasmagen Biosciences Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 4.98% increase. The company also saw a substantial fall in profitability, with a 298.3% decrease in profit. The company's net worth Soared by an impressive increase of 57.97%.

Plasmagen Biosciences revenue growth over time
Plasmagen Biosciences profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 4.98%
*******
*******
*******
*******
Revenue from Operations
*******
 4.63%
*******
*******
*******
*******
Total Assets
*******
 56.77%
*******
*******
*******
*******
Profit or Loss
*******
 -298.30%
*******
*******
*******
*******
Net Worth
*******
 57.97%
*******
*******
*******
*******
EBITDA
*******
 -275.76%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Plasmagen Biosciences?

In 2023, Plasmagen Biosciences had a promoter holding of 79.45% and a public holding of 20.55%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹3,052,524,000.00

Satisfied Charges

₹205,500,000.00

Charges Breakdown by Lending Institutions
  • Sbicap Trustee Company Limited : 210.00 Cr
  • Hdfc Bank Limited : 50.00 Cr
  • Others : 45.25 Cr
Latest Charge Details
Date Lender Amount Status
17 Jun 2025 Hdfc Bank Limited ₹30.00 Cr Open
29 Mar 2025 Others ₹30.00 Cr Open
06 Sep 2024 Sbicap Trustee Company Limited ₹45.00 Cr Open
22 Jun 2022 Hdfc Bank Limited ₹20.00 Cr Open
31 Mar 2022 Others ₹2.52 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Plasmagen Biosciences?

Plasmagen Biosciences has a workforce of 262 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Plasmagen Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Plasmagen Biosciences's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Plasmagen Biosciences
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Plasmagen Biosciences Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Charges

    The activity A charge with Hdfc Bank Limited amounted to Rs. 30.00 Cr with Charge ID 101115155 was registered on 17 Jun 2025. was completed.

  • Balance Sheet

    The activity Plasmagen Biosciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore. was completed.

  • Charges

    Progress on A charge with Others amounted to Rs. 30.00 Cr with Charge ID 101128994 was registered on 29 Mar 2025. was documented.

  • Charges

    The activity A charge with Sbicap Trustee Company Limited amounted to Rs. 45.00 Cr with Charge ID 100970548 was registered on 06 Sep 2024. was completed.

  • Charges

    The activity A charge with Hdfc Bank Limited amounted to Rs. 20.00 Cr with Charge ID 100591660 was registered on 22 Jun 2022. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Plasmagen Biosciences Private Limited?

The CIN of Plasmagen Biosciences Private Limited is U51909KA2010PTC055077.

Where is Plasmagen Biosciences Private Limited headquartered?

Plasmagen Biosciences Private Limited is headquartered at No. 160, Kci Chambers, 2Nd Floor, 5Th Main Road, Chamarajpet, Bangalore, Karnataka, 560018.

When was Plasmagen Biosciences Private Limited incorporated?

Plasmagen Biosciences Private Limited was incorporated on 07 September 2010.

Who are the current directors of Plasmagen Biosciences Private Limited?

The current directors of Plasmagen Biosciences Private Limited are

What is the primary industry of Plasmagen Biosciences Private Limited?

The primary industry of Plasmagen Biosciences Private Limited is Trade.

Is Plasmagen Biosciences Private Limited a listed company?

Plasmagen Biosciences Private Limited is unlisted.

What is the capital structure of Plasmagen Biosciences Private Limited?

The authorized capital of Plasmagen Biosciences Private Limited is ₹114.85 Cr, and the paid-up capital is ₹114.34 Cr.

What is the compliance status of Plasmagen Biosciences Private Limited?

The compliance status of Plasmagen Biosciences Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available